tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ITOS Stock Latest News

iTeos Therapeutics presents preclinical data on EOS-984
The FlyiTeos Therapeutics presents preclinical data on EOS-984
11d ago
ITOS
iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024
PremiumPress Releases
iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024
11d ago
ITOS
iTeos Therapeutics management to meet with Piper Sandler
PremiumThe Fly
iTeos Therapeutics management to meet with Piper Sandler
1M ago
ITOS
iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
PremiumPress Releases
iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
1M ago
ITOS
iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors
PremiumPress Releases
iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors
1M ago
ITOS
iTeos Therapeutics reports Q4 EPS (85c), consensus ($1.03)
PremiumThe FlyiTeos Therapeutics reports Q4 EPS (85c), consensus ($1.03)
1M ago
ITOS
iTeos Therapeutics appoints DeSimone to board of directors
PremiumThe Fly
iTeos Therapeutics appoints DeSimone to board of directors
1M ago
MRK
ITOS
iTeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024
PremiumPress Releases
iTeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024
1M ago
ITOS
iTeos to Participate in Upcoming Investor Conferences
PremiumPress Releases
iTeos to Participate in Upcoming Investor Conferences
2M ago
ITOS
iTeos Therapeutics announces 2024 strategic priorities, anticipated milestones
PremiumThe Fly
iTeos Therapeutics announces 2024 strategic priorities, anticipated milestones
3M ago
ITOS
iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference
PremiumPress Releases
iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference
5M ago
ITOS
iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates
PremiumPress Releases
iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates
5M ago
ITOS
iTeos Therapeutics expects cash to provide runway through 2026
PremiumThe FlyiTeos Therapeutics expects cash to provide runway through 2026
5M ago
ITOS
iTeos Therapeutics reports Q3 EPS (90c), consensus ($1.20)
PremiumThe Fly
iTeos Therapeutics reports Q3 EPS (90c), consensus ($1.20)
5M ago
ITOS
iTeos Therapeutics participates in a conference call with JPMorgan
PremiumThe Fly
iTeos Therapeutics participates in a conference call with JPMorgan
6M ago
ITOS
iTeos Therapeutics participates in a conference call with JPMorgan
PremiumThe Fly
iTeos Therapeutics participates in a conference call with JPMorgan
6M ago
ITOS
National Interstate to replace iTeos in S&P 600 at open on 10/18
PremiumThe Fly
National Interstate to replace iTeos in S&P 600 at open on 10/18
6M ago
NCR
ITOS
National Interstate to replace iTeos in S&P 600 at open on 10/18
PremiumThe Fly
National Interstate to replace iTeos in S&P 600 at open on 10/18
6M ago
NCR
ITOS
iTeos to Participate in Upcoming Investor Conferences
PremiumPress Releases
iTeos to Participate in Upcoming Investor Conferences
8M ago
ITOS
iTeos should be up ‘sharply’ on Roche data, says Piper Sandler
PremiumThe FlyiTeos should be up ‘sharply’ on Roche data, says Piper Sandler
8M ago
ITOS
iTeos jumps after Roche inadvertently publishes positive TIGIT data
PremiumThe Fly
iTeos jumps after Roche inadvertently publishes positive TIGIT data
8M ago
ITOS
iTeos Therapeutics price target lowered to $44 from $54 at H.C. Wainwright
PremiumThe Fly
iTeos Therapeutics price target lowered to $44 from $54 at H.C. Wainwright
8M ago
ITOS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >